Corteva, Inc. Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025, for Corteva, Inc. and its subsidiary EIDP, Inc. Corteva operates in two reportable segments: Seed and Crop Protection. The filing includes unaudited consolidated financial statements and management discussion. EIDP, Inc. is a wholly-owned subsidiary of Corteva and continues to file separately due to legacy reporting requirements, though its financials are consolidated into Corteva's results.
Key Financial Metrics
| Metric (in millions) | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Sales | $4,417 | $4,492 |
| Cost of Goods Sold | $2,342 | $2,550 |
| Gross Margin | 47.0% | 43.2% |
| Operating EBITDA (Non-GAAP) | $1,189 | $1,034 |
| Net Income (Attributable to Corteva) | $652 | $419 |
| Diluted EPS | $0.95 | $0.60 |
| Cash and Cash Equivalents | $2,008 | $1,505 |
| Total Debt | $4,083 | $4,640 |
| Operating Cash Flow (Continuing Ops) | $(2,101) | $(2,606) |
Note: Operating cash flow is negative due to seasonal working capital requirements typical for the agricultural industry in Q1.
Material Changes vs. Prior Period
- Revenue: Net sales decreased 2% year-over-year, driven by a 5% unfavorable currency impact (notably Brazilian Real, Euro, Turkish Lira), partially offset by a 2% volume increase and 1% price increase.
- Profitability: Net income attributable to Corteva increased 56% to $652 million. This was driven by lower restructuring charges ($22 million vs. $75 million), improved cost of goods sold (53% of sales vs. 57%), and a lower effective tax rate (14.9% vs. 22.0%).
- Segment Performance:
- Seed: Sales down 2%; Operating EBITDA up 13% ($842 million) due to price execution and cost benefits.
- Crop Protection: Sales down 2%; Operating EBITDA up 22% ($377 million) driven by volume growth and raw material deflation.
- Debt: Total debt decreased to $4.08 billion from $4.64 billion, though short-term borrowings increased to fund seasonal working capital needs.
Guidance, Outlook, and Risks
- Restructuring: The "Crop Protection Operations Strategy Restructuring Program" is ongoing. Total expected charges are $650–$700 million. Through Q1 2025, $487 million has been recorded. The program aims to generate $180 million in run-rate savings by 2027.
- Capital Allocation: The company returned $385 million to shareholders in Q1 via dividends ($116 million) and share repurchases ($270 million). Management expects approximately $1 billion in repurchases for the full year 2025.
- Legal and Environmental Risks:
- PFAS Litigation: Significant exposure remains regarding legacy PFAS liabilities shared with Chemours and DuPont under a Memorandum of Understanding (MOU). Discontinued operations recorded an $11 million loss related to PFAS remediation.
- Antitrust: The FTC and multiple state attorneys general have filed lawsuits alleging anticompetitive conduct. Trials are expected to begin in 2026.
- Regulatory: Risks related to funding and staff reductions at the EPA and USDA could delay regulatory approvals for genetically modified seeds.
- Internal Controls (EIDP): EIDP, Inc. disclosed a material weakness in internal controls regarding the classification of intercompany cash flows, which has been restated. A remediation plan is in place.
Investor Verification Checklist
- Seasonal Cash Flow: Verify the sustainability of negative operating cash flow in Q1 against historical seasonal patterns and working capital management.
- Restructuring Progress: Monitor the execution of the Crop Protection restructuring program and the realization of the projected $180 million in annual savings.
- PFAS Liability Exposure: Review updates on the MOU with Chemours/DuPont and the status of the MOU Escrow Account to assess potential future cash outflows.
- Antitrust Litigation: Track the timeline and potential outcomes of the FTC and state attorney general lawsuits, including the 2026 trial date.
- Currency Sensitivity: Assess the impact of continued volatility in the Brazilian Real and Euro on future revenue and earnings.